SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-19-000107
Filing Date
2019-08-07
Accepted
2019-08-07 08:30:23
Documents
3
Period of Report
2019-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2019q2earnings.htm 8-K 29685
2 EXHIBIT 99.1 exhibit2q19.htm EX-99.1 130778
3 ljpcpressrelease_image1a25.jpg GRAPHIC 21134
  Complete submission text file 0000920465-19-000107.txt   190842
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 191003941
SIC: 2836 Biological Products, (No Diagnostic Substances)